Nanotechnology and its use in imaging and drug delivery (Review)

Sim,Serjay; Wong,Nyet Kui

doi:10.3892/br.2021.1418

Nanotechnology and its use in imaging and drug delivery (Review)

Authors:
- Serjay Sim
- Nyet Kui Wong
View Affiliations

Affiliations: School of Health Sciences, Division of Applied Biomedical Sciences and Biotechnology, International Medical University, Kuala Lumpur 57000, Malaysia
Published online on: March 5, 2021 https://doi.org/10.3892/br.2021.1418
Article Number: 42

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nanotechnology is the exploitation of the unique properties of materials at the nanoscale. Nanotechnology has gained popularity in several industries, as it offers better built and smarter products. The application of nanotechnology in medicine and healthcare is referred to as nanomedicine, and it has been used to combat some of the most common diseases, including cardiovascular diseases and cancer. The present review provides an overview of the recent advances of nanotechnology in the aspects of imaging and drug delivery.

View Figures

View References

1	Drexler KE: Nanosystems: Molecular Machinery, Manufacturing, and Computation. John Wiley & Sons, New York, NY, 1989.
2	Drexler KE: Engines of Creation: The Coming Era of Nanotechnology. Anchor Books, Doubleday, 1986.
3	Belkin A, Hubler A and Bezryadin A: Self-assembled wiggling nano-structures and the principle of maximum entropy production. Sci Rep. 5(8323)2015.PubMed/NCBI View Article : Google Scholar
4	Buzea C, Pacheco II and Robbie K: Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases. 2:MR17–MR71. 2007.PubMed/NCBI View Article : Google Scholar
5	Kroto HW, Heath O Jr, O'Brien SC, Curl RF and Smalley RE: Buckminsterfullerene. This Week's Citation Classic. Nature. 318:162–163. 1985.
6	Allhoff F, Patrick L and Daniel M: What is Nanotechnology and Why Does it Matter? From Science to Ethics. John Wiley & Sons, pp3-5, 2010.
7	Mashaghi S, Jadidi T, Koenderink G and Mashaghi A: Lipid nanotechnology. Int J Mol Sci. 14:4242–4282. 2013.PubMed/NCBI View Article : Google Scholar
8	Farokhzad OC and Langer R: Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev. 58:1456–1459. 2006.PubMed/NCBI View Article : Google Scholar
9	Filipponi L and Nicolau DV: Cell Patterning. Wiley Encyclopedia of Biomedical Engineering. John Wiley & Sons, 2006.
10	Lombardo D, Kiselev MA and Caccamo MT: Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine. J Nanomater. 12:1–26. 2019.
11	Katsuki S, Matoba T, Koga JI, Nakano K and Egashira K: Anti-inflammatory Nanomedicine for Cardiovascular Disease. Front Cardiovasc Med. 4(87)2017.PubMed/NCBI View Article : Google Scholar
12	Morgan MT, Carnahan MA, Finkelstein S, Prata CA, Degoricija L, Lee SJ and Grinstaff MW: Dendritic supramolecular assemblies for drug delivery. Chem Commun (Camb). 97:4309–4311. 2005.PubMed/NCBI View Article : Google Scholar
13	Tiriveedhi V, Kitchens KM, Nevels KJ, Ghandehari H and Butko P: Kinetic analysis of the interaction between poly(amidoamine) dendrimers and model lipid membranes. Biochim Biophys Acta. 1808:209–218. 2011.PubMed/NCBI View Article : Google Scholar
14	Palmerston Mendes L, Pan J and Torchilin VP: Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules. 22(1401)2017.PubMed/NCBI View Article : Google Scholar
15	Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA and Baker JR Jr: Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA. 93:4897–4902. 1996.PubMed/NCBI View Article : Google Scholar
16	Svenson S and Tomalia DA: Dendrimers in biomedical applications - reflections on the field. Adv Drug Deliv Rev. 57:2106–2129. 2005.PubMed/NCBI View Article : Google Scholar
17	Nune SK, Gunda P, Thallapally PK, Lin YY, Forrest ML and Berkland CJ: Nanoparticles for biomedical imaging. Expert Opin Drug Deliv. 6:1175–1194. 2009.PubMed/NCBI View Article : Google Scholar
18	Shi Kam NW, Jessop TC, Wender PA and Dai H: Nanotube molecular transporters: Internalization of carbon nanotube-protein conjugates into Mammalian cells. J Am Chem Soc. 126:6850–6851. 2004.PubMed/NCBI View Article : Google Scholar
19	Pantarotto D, Briand JP, Prato M and Bianco A: Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb). 7:16–17. 2004.PubMed/NCBI View Article : Google Scholar
20	Dai HJ, Hafner JH, Rinzler AG, Colbert DT and Smalley RE: Nanotubes as nanoprobes in scanning probe microscopy. Nature. 384:147–150. 1996.
21	Acharya S and Sahoo SK: PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 63:170–183. 2011.PubMed/NCBI View Article : Google Scholar
22	Mulder WJ, Strijkers GJ, van Tilborg GA, Cormode DP, Fayad ZA and Nicolay K: Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res. 42:904–914. 2009.PubMed/NCBI View Article : Google Scholar
23	Probst CE, Zrazhevskiy P, Bagalkot V and Gao X: Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev. 65:703–718. 2013.PubMed/NCBI View Article : Google Scholar
24	Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI and Radomski MW: Nanoparticles: Pharmacological and toxicological significance. Br J Pharmacol. 150:552–558. 2007.PubMed/NCBI View Article : Google Scholar
25	Ratner BD and Bryant SJ: Biomaterials: Where we have been and where we are going. Annu Rev Biomed Eng. 6:41–75. 2004.PubMed/NCBI View Article : Google Scholar
26	Sakiyama-Elbert SE and Hubbell JA: Functional biomaterials: Design of novel biomaterials. Annu Rev Mater Res. 31:183–201. 2001.
27	Wickline SA and Lanza GM: Nanotechnology for molecular imaging and targeted therapy. Circulation. 107:1092–1095. 2003.PubMed/NCBI View Article : Google Scholar
28	Lanone S and Boczkowski J: Biomedical applications and potential health risks of nanomaterials: Molecular mechanisms. Curr Mol Med. 6:651–663. 2006.PubMed/NCBI View Article : Google Scholar
29	Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, West J and Drezek R: Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat. 3:33–40. 2004.PubMed/NCBI View Article : Google Scholar
30	Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP, Bashir R, et al: A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 7:3759–3765. 2007.PubMed/NCBI View Article : Google Scholar
31	Abbasi A, Park K, Bose A and Bothun GD: Near-Infrared Responsive Gold-Layersome Nanoshells. Langmuir. 33:5321–5327. 2017.PubMed/NCBI View Article : Google Scholar
32	Helm L: Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications. Future Med Chem. 2:385–396. 2010.PubMed/NCBI View Article : Google Scholar
33	Vo-Dinh T and Cullum B: Biosensors and biochips: Advances in biological and medical diagnostics. Fresenius J Anal Chem. 366:540–551. 2000.PubMed/NCBI View Article : Google Scholar
34	Silva GA: Neuroscience nanotechnology: Progress, opportunities and challenges. Nat Rev Neurosci. 7:65–74. 2006.PubMed/NCBI View Article : Google Scholar
35	Yan Z, Bin Y and Deng YH: Take the initiative to drug-loaded liposomes prepared by vincristine sulfate and the determination of encapsulation efficiency. Chung Kuo Yao Hsueh Tsa Chih. 10(1559)2005.
36	Ochekpe NA, Olorunfemi PO and Ngwuluka NC: Nanotechnology and drug delivery part 1: Background and applications. Trop J Pharm Res. 8:265–274. 2009.
37	Zalipsky S: Polyethylene glycol-lipid conjugates. In: Stealth Liposomes. CRC Press, Boca Raton, pp93-102, 1995.
38	Jain N, Jain R, Thakur N, Gupta BP and Jain DK: Nanotechnology: A Safe and effective drug delivery system. Asian J Pharm Clin Res. 3:159–165. 2010.
39	Kakade T, Kadam V, Dhanavade K and Salunkhe V: A review on pharmaceutical nanotechnology: Dendrimers. World J Pharm Pharm Sci. 2:4815–4830. 2013.
40	Tibbals HF: Medical Nanotechnology and Nanomedicine. CRC Press, Taylor and Francis Group 31, 2011.
41	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013.PubMed/NCBI View Article : Google Scholar
42	van Vlerken LE, Vyas TK and Amiji MM: Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res. 24:1405–1414. 2007.PubMed/NCBI View Article : Google Scholar
43	Biswas AK, Islam R, Choudhury ZS, Mostafa A and Kadir MF: Nanotechnology based approaches in cancer therapeutics. Adv Nat Sci Nanosci Nanotechnol. 5:2043–6262. 2004.
44	Gupta P, Vermani K and Garg S: Hydrogels: From controlled release to pH-responsive drug delivery. Drug Discov Today. 7:569–579. 2002.PubMed/NCBI View Article : Google Scholar
45	Montero AJ, Adams B, Diaz-Montero CM and Glück S: Nab-paclitaxel in the treatment of metastatic breast cancer: A comprehensive review. Expert Rev Clin Pharmacol. 4:329–334. 2011.PubMed/NCBI View Article : Google Scholar
46	Tsurutani J, Kuroi K, Iwasa T, Miyazaki M, Nishina S, Makimura C, Tanizaki J, Okamoto K, Yamashita T, Aruga T, et al: Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer. Cancer Sci. 106:734–739. 2015.PubMed/NCBI View Article : Google Scholar
47	McGill HC Jr, McMahan CA and Gidding SS: Preventing heart disease in the 21st century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation. 117:1216–1227. 2008.PubMed/NCBI View Article : Google Scholar
48	Das A, Mukherjee P, Singla SK, Guturu P, Frost MC, Mukhopadhyay D, Shah VH and Patra CR: Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide. Nanotechnology. 21(305102)2010.PubMed/NCBI View Article : Google Scholar
49	Deshpande D, Kethireddy S, Janero DR and Amiji MM: Therapeutic efficacy of an ω-3-fatty acidcontaining 17-β estradiol nano-delivery system against experimental atherosclerosis. PLoS One. 11(e0147337)2016.PubMed/NCBI View Article : Google Scholar
50	Wu T, Chen X, Wang Y, Xiao H, Peng Y, Lin L, Xia W, Long M, Tao J and Shuai X: Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation. Nanomedicine (Lond). 14:2215–2226. 2018.PubMed/NCBI View Article : Google Scholar
51	Bulbake U, Doppalapudi S, Kommineni N and Khan W: Liposomal formulations in clinical use: An updated review. Pharmaceutics. 9(12)2017.PubMed/NCBI View Article : Google Scholar
52	Zhang N, Li C, Zhou D, Ding C, Jin Y, Tian Q, Meng X, Pu K and Zhu Y: Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis. Acta Biomater. 70:227–236. 2018.PubMed/NCBI View Article : Google Scholar
53	Najlah M, Freeman S, Attwood D and D'Emanuele A: In vitro evaluation of dendrimer prodrugs for oral drug delivery. Int J Pharm. 336:183–190. 2007.PubMed/NCBI View Article : Google Scholar
54	Korin N, Gounis MJ, Wakhloo AK and Ingber DE: Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics. JAMA Neurol. 72:119–122. 2015.PubMed/NCBI View Article : Google Scholar
55	Sahaym U and Norton M: Advances in the application of nanotechnology in enabling a hydrogen economy. J Mater Sci. 43:5395–5429. 2008.
56	Rickerby DG and Morrison M: Nanotechnology and the environment: A European perspective. Sci Technol Adv Mater. 8:19–24. 2007.
57	Hoshyar N, Gray S, Han H and Bao G: The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond). 11:673–692. 2016.PubMed/NCBI View Article : Google Scholar
58	Lee JM, Yoon TJ and Cho YS: Recent developments in nanoparticle-based siRNA delivery for cancer therapy. BioMed Res Int. 2013(782041)2013.PubMed/NCBI View Article : Google Scholar
59	Asmatulu R and Asmatulu E: Importance of recycling education: A curriculum development at Wichita State University. J Mater Cycles Waste Manag. 14:1–8. 2011.
60	Narayan RJ, Kumta PN, Sfeir C, Lee DH, Choi D and Olton D: Nanostructured ceramics in medical devices: Applications and prospects. JOM. 56:38–43. 2004.
61	Byrne JD and Baugh JA: The significance of nanoparticles in particle-induced pulmonary fibrosis. Mcgill J Med. 11:43–50. 2008.PubMed/NCBI
62	Hubler A and Osuagwu O: Digital quantum batteries: Energy and information storage in nanovacuum tube arrays. Complexity. 15:48–55. 2010.
63	Shinn E, Hübler A, Lyon D, Perdekamp M, Bezryadin A and Belkin A: Nuclear energy conversion with stacks of graphene nanocapacitors. Complexity. 18:24–27. 2012.
64	Kurtoglu ME, Longenbach T, Reddington P and Gogotsi Y: Effect of calcination temperature and environment on photocatalytic and mechanical properties of ultrathin sol-gel titanium dioxide films. J Am Ceram Soc. 94:1101–1108. 2011.
65	Prencipe G, Tabakman SM, Welsher K, Liu Z, Goodwin AP, Zhang L, Henry J and Dai H: PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc. 131:4783–4787. 2009.PubMed/NCBI View Article : Google Scholar
66	Swanson SD, Kukowska-Latallo JF, Patri AK, Chen C, Ge S, Cao Z, Kotlyar A, East AT and Baker JR: Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int J Nanomedicine. 3:201–210. 2008.PubMed/NCBI
67	Waters EA and Wickline SA: Contrast agents for MRI. Basic Res Cardiol. 103:114–121. 2008.PubMed/NCBI View Article : Google Scholar
68	Smith AM, Duan H, Mohs AM and Nie S: Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev. 60:1226–1240. 2008.PubMed/NCBI View Article : Google Scholar
69	Wunderbaldinger P, Josephson L, Bremer C, Moore A and Weissleder R: Detection of lymph node metastases by contrast-enhanced MRI in an experimental model. Magn Reson Med. 47:292–297. 2002.PubMed/NCBI View Article : Google Scholar
70	Thorek DL and Tsourkas A: Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials. 29:3583–3590. 2008.PubMed/NCBI View Article : Google Scholar
71	Nie L, Liu F, Ma P and Xiao X: Applications of gold nanoparticles in optical biosensors. J Biomed Nanotechnol. 10:2700–2721. 2014.PubMed/NCBI View Article : Google Scholar
72	Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M and Akbarzadeh A: Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 44:410–422. 2016.PubMed/NCBI View Article : Google Scholar
73	Cole LE, Ross RD, Tilley JM, Vargo-Gogola T and Roeder RK: Gold nanoparticles as contrast agents in x-ray imaging and computed tomography. Nanomedicine (Lond). 10:321–341. 2015.PubMed/NCBI View Article : Google Scholar
74	Hwang S, Nam J, Jung S, Song J, Doh H and Kim S: Gold nanoparticle-mediated photothermal therapy: Current status and future perspective. Nanomedicine (Lond). 9:2003–2022. 2014.PubMed/NCBI View Article : Google Scholar
75	Park JA, Lee JJ, Jung JC, Yu DY, Oh C, Ha S, Kim TJ and Chang Y: Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent. ChemBioChem. 9:2811–2813. 2008.PubMed/NCBI View Article : Google Scholar
76	Zhang W, Yong D, Huang J, Yu J, Liu S and Fan MX: Fabrication of polymer-gadolinium (III) complex nanomicelle from poly(ethylene glycol)-polysuccinimide conjugate and diethylenetriaminetetraacetic acid-gadolinium as magnetic resonance imaging contrast agents. J Appl Polym Sci. 120:2596–2605. 2011.
77	Karfeld-Sulzer LS, Waters EA, Davis NE, Meade TJ and Barron AE: Multivalent protein polymer MRI contrast agents: Controlling relaxivity via modulation of amino acid sequence. Biomacromolecules. 11:1429–1436. 2010.PubMed/NCBI View Article : Google Scholar
78	Kamaly N and Miller AD: Paramagnetic liposome nanoparticles for cellular and tumour imaging. Int J Mol Sci. 11:1759–1776. 2010.PubMed/NCBI View Article : Google Scholar
79	Na HB, Song IC and Hyeon T: Inorganic Nanoparticles for MRI Contrast Agents. Adv Mater. 21:2133–2148. 2019.
80	Shao YZ, Liu LZ, Song SQ, Cao RH, Liu H, Cui CY, Li X, Bie MJ and Li L: A novel one-step synthesis of Gd3⁺-incorporated mesoporous SiO₂ nanoparticles for use as an efficient MRI contrast agent. Contrast Media Mol Imaging. 6:110–118. 2011.PubMed/NCBI View Article : Google Scholar
81	Bobo D, Robinson KJ, Islam J, Thurecht KJ and Corrie SR: Nanoparticle-based medicines: A review of FDA-approved materials and clinical trials to date. Pharm Res. 33:2373–2387. 2016.PubMed/NCBI View Article : Google Scholar
82	Qiao R, Yang C and Gao M: Superparamagnetic iron oxide nanoparticles: From preparations to in vivo MRI applications. J Mater Chem. 19:6274–6293. 2009.
83	Teja AS and Koh P: Synthesis, properties, and applications of magnetic iron oxide nanoparticles. Prog Cryst Growth Charact Mater. 55:22–45. 2009.
84	Murbe J, Rechtenbach A and Topfer J: Synthesis and physical characterisation of magnetite nanoparticles for biomedical applications. Mater Chem Phys. 110:426–433. 2008.
85	Sun C, Lee JS and Zhang M: Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 60:1252–1265. 2008.PubMed/NCBI View Article : Google Scholar
86	Hong J, Gong P, Xu D, Sun H and Yao S: Synthesis and characterisation of carboxyl functionalised magnetic nanogel via ‘green’ photochemical method. J Appl Polym Sci. 105:1882–1887. 2007.
87	Gupta AK and Gupta M: Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 26:3995–4021. 2005.PubMed/NCBI View Article : Google Scholar
88	Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G and Weissleder R: An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater. 5:118–122. 2006.PubMed/NCBI View Article : Google Scholar
89	Hahn MA, Singh AK, Sharma P, Brown SC and Moudgil BM: Nanoparticles as contrast agents for in-vivo bioimaging: Current status and future perspectives. Anal Bioanal Chem. 399:3–27. 2011.PubMed/NCBI View Article : Google Scholar
90	Elrod DB, Partha R, Danila D, Casscells SW and Conyers JL: An iodinated liposomal computed tomographic contrast agent prepared from a diiodophosphatidylcholine lipid. Nanomedicine (Lond). 5:42–45. 2009.PubMed/NCBI View Article : Google Scholar
91	Kweon S, Lee HJ, Hyung WJ, Suh J, Lim JS and Lim SJ: Liposomes coloaded with iopamidol/lipiodol as a RES-targeted contrast agent for computed tomography imaging. Pharm Res. 27:1408–1415. 2010.PubMed/NCBI View Article : Google Scholar
92	Zheng J, Allen C, Serra S, Vines D, Charron M and Jaffray DA: Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: Validation with FDG-PET and histology. Contrast Media Mol Imaging. 5:147–154. 2010.PubMed/NCBI View Article : Google Scholar
93	Chrastina A and Schnitzer JE: Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int J Nanomedicine. 5:653–659. 2010.PubMed/NCBI View Article : Google Scholar
94	Van Herck JL, De Meyer GR, Martinet W, Salgado RA, Shivalkar B, De Mondt R, Van De Ven H, Ludwig A, Van Der Veken P, Van Vaeck L, et al: Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits. Basic Res Cardiol. 105:51–59. 2010.PubMed/NCBI View Article : Google Scholar
95	Aillon KL, El-Gendy N, Dennis C, Norenberg JP, McDonald J and Berkland C: Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization. Mol Pharm. 7:1274–1282. 2010.PubMed/NCBI View Article : Google Scholar
96	Hainfeld JF, Slatkin DN, Focella TM and Smilowitz HM: Gold nanoparticles: A new X-ray contrast agent. Br J Radiol. 79:248–253. 2006.PubMed/NCBI View Article : Google Scholar
97	Kim D, Park S, Lee JH, Jeong YY and Jon S: Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc. 129:7661–7665. 2007.PubMed/NCBI View Article : Google Scholar
98	Pan J, Wang Y and Feng SS: Formulation, characterization, and in vitro evaluation of quantum dots loaded in poly(lactide)-vitamin E TPGS nanoparticles for cellular and molecular imaging. Biotechnol Bioeng. 101:622–633. 2008.PubMed/NCBI View Article : Google Scholar
99	Yang L, Mao H, Wang YA, Cao Z, Peng X, Wang X, Duan H, Ni C, Yuan Q, Adams G, et al: Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small. 5:235–243. 2009.PubMed/NCBI View Article : Google Scholar
100	Ballou B, Ernst LA and Waggoner AS: Fluorescence imaging of tumors in vivo. Curr Med Chem. 12:795–805. 2005.PubMed/NCBI View Article : Google Scholar
101	Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JA, Waggoner AS and Bruchez MP: Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem. 18:389–396. 2007.PubMed/NCBI View Article : Google Scholar
102	Serp P, Corrias M and Kalck P: Carbon nanotubes and nanofibers in catalysis. Appl Catal. 253:337–358. 2003.
103	Ghosh M, Singh AT, Xu W, Sulchek T, Gordon LI and Ryan RO: Curcumin nanodisks: Formulation and characterization. Nanomedicine (Lond). 7:162–167. 2011.PubMed/NCBI View Article : Google Scholar
104	Singh P: Impacts of nanotechnology on environmental (Review). Int Arch App Sci Technol. 9:14–16. 2018.
105	Chandarana M, Curtis A and Hoskins C: The use of nanotechnology in cardiovascular disease. Appl Nanosci. 8:1607–1619. 2018.
106	Dreher KL: Health and environmental impact of nanotechnology: Toxicological assessment of manufactured nanoparticles. Toxicol Sci. 77:3–5. 2004.PubMed/NCBI View Article : Google Scholar
107	Lam CW, James JT, McCluskey R and Hunter RL: Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 77:126–134. 2004.PubMed/NCBI View Article : Google Scholar
108	Stander L and Theodore L: Environmental implications of nanotechnology - an update. Int J Environ Res Public Health. 8:470–479. 2011.PubMed/NCBI View Article : Google Scholar
109	Babatunde D, Denwigwe IH, Babatunde OM, Gbadamosi SL, Babalola IP and Agboola O: Environmental and Societal Impact of Nanotechnology. IEEE Access. 8:4640–4667. 2020.